MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

Table 1

Target genes of miR-30a in response to cancer cells.

Target gene	Cancer type	References
SEPT7	Glioma cancer	Jia Z et al. [6]
AEG-1	lung cancer	Liu K et al. [8]
Eya2	Breast cancer	Fu J et al. [11]
Vimentin	Breast cancer	Cheng CW et al. [12]
UBE3C	Breast cancer	Xiong J et al. [14]
NCAM	glioma	Wang Z et al. [16]
MTDH	liver cancer	Li WF et al. [18]
HP1γ	Colorectal Cancer	Liu M et al. [19]
PIK3CD	Colorectal Carcinoma	Zhong M et al. [20]
RPA1	ovarian cancer,; gastric cancer	Zou Z et al. [21]
Runx2		chondrosarcoma	Jiang D et al. [22]
RUNX3	gastric cancer	Liu Z et al [23]
Notch1	urothelial carcinoma	Zhang C et al. [25]
	of the bladder
E-cadherin	nasopharyngeal carcinoma	Wang HY et al. [26]
EWS-FLI1	Ewing tumor	Franzetti GA et al. [27]
CD99	Ewing tumor	Franzetti GA et al. [27]
PRDM1.	glioma	Wang X et al. [34]
EZH2	malignant peripheral	Zhang P et al. [38]
	nerve sheath tumor
IGF1R	in non-small cell lung cancer,	Wen XP et al. [40],
IRS2	Colorectal cancer	Zhang Q et al. [41]
SOX4	chondrosarcoma	Lu N at al. [42]
Slug	Breast cancer	Chang CW et al. [47]
β3 integrin	Breast cancer	Li W et al. [48]
Snai1	lung cancer,	Kumarswamy R et al. [49],
	hepatocellular carcinoma	Liu Z et al. [50]
ITGB3	Colorectal Carcinoma	Wei W et al [51]
EYA2	lung cancer	Yuan Y et al. [52]
DTL	colon carcinoma	Baraniskin A et al. [53]
Skp2	Pulmonary Vascular	Qi F et al. [54]
	Hyperpermeability
p53	hepatocellular carcinoma	Park D et al. [55]
HNF4γ	intestinal metaplasia	Sousa JF et al. [56]
ET	ovarian carcinoma	Sestito R et al. [57]
beclin 1	lung cancer, Breast cancer	Zhu H et al. [58]
FOXL2	ovarian	Wang T, et al. [59]